VP35 (AA 1-329) Antikörper (Biotin)
-
- Target
- VP35
- Bindungsspezifität
- AA 1-329
- Reaktivität
- Reston Ebola virus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Biotin
- Applikation
- ELISA
- Kreuzreaktivität
- Reston Ebola virus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Reston ebolavirus Polymerase cofactor VP35 protein (1-329AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- VP35
- Hintergrund
-
Background: Acts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. This blockage is produced through the interaction with and inhibition host IKBKE and TBK1 producing a strong inhibition of the phosphorylation and activation of IRF3. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR.
Aliases: VP35 antibody, Polymerase cofactor VP35 antibody
- UniProt
- Q91DE0
-